Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 15INDUSTRY 9NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 257Gastrointestinal 53Breast 43Genitourinary 42Gynecologic 23Dermatologic 21Other solid neoplasm 18Lymphoid 17Other hematologic neoplasm 14Head & Neck 14Sarcoma 12CNS 12Plasma cell 5Endocrine 5Other 3Other neoplasm 1NET 1Myeloid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 50Myelodysplastic Syndromes 40Leukemia, Myeloid, Acute 34Leukemia, Myelomonocytic, Chronic 33Leukemia 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myeloproliferative Disorders 18Congenital Abnormalities 17Leukemia, Lymphocytic, Chronic, B-Cell 16Anemia, Refractory 15Blast Crisis 14Anemia 14Myelodysplastic-Myeloproliferative Diseases 10Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Myeloid, Accelerated Phase 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Neoplasms 8Lymphoma, Follicular 8Lymphoma 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Monocytic, Acute 8Anemia, Aplastic 8Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Thrombocytopenia 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6

Interventions

continuous erythropoietin receptor activator 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lung Neoplasms × Classical hematology × Clear all
NCT00072059 2013-07-18

Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡